Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Gmo Product Platform's earnings per share without non-recurring items for the
three
months ended in Dec. 2025 was 円0.00.
Its earnings per share without non-recurring items for the trailing twelve months (TTM) ended in Dec. 2025 was 円89.90.
During the past 12 months, Gmo Product Platform's average earnings per share (NRI) Growth Rate was -54.50% per year.
During the past 3 years, the average earnings per share (NRI) Growth Rate was -37.90% per year.
During the past 5 years, the average earnings per share (NRI) Growth Rate was -12.90% per year.
During the past 10 years, the average earnings per share (NRI) Growth Rate was 4.90% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using Earnings per share without Non-Recurring Items (NRI) data.
The historical rank and industry rank for Gmo Product Platform's EPS without NRI or its related term are showing as below:
TSE:3695'
s 3-Year EPS without NRI Growth Rate Range Over the Past 10 Years
Min: -37.9 Med: 10.95 Max: 38.9
Current: -37.9
During the past 13 years, Gmo Product Platform's highest 3-Year average Earnings Per Share (NRI) Growth Rate was 38.90% per year. The lowest was -37.90% per year. And the median was 10.95% per year.
TSE:3695's 3-Year EPS without NRI Growth Rate is ranked worse than 90.47% of 2077
companies
in the Software industry
Industry Median: 12.5
vs TSE:3695: -37.90
Gmo Product Platform's EPS (Basic) for the
three
months ended in Dec. 2025 was 円0.00.
Its EPS (Basic) for the trailing twelve months (TTM) ended in Dec. 2025 was 円81.08.
Gmo Product Platform (TSE:3695) EPS without NRI Explanation
EPS without NRI removes onetime and unusual items from EPS, to provide investors with a more accurate measure of the company’s true earnings. The earnings are adjusted for items that are irregular or unusual in nature, and/or are non-recurring. This is calculated using Net Income (Continuing Operations) plus/minus any tax affected unusual Items and Goodwill Impairments/Write Offs. This can be used to fairly measure a company's profitability.
Be Aware
Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.
If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.
Gmo Product Platform EPS without NRI Related Terms
Gmo Product Platform EPS without NRI Historical Data
* Premium members only.
The historical data trend for Gmo Product Platform's EPS without NRI can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
TSE:3695 vs MSFT, ORCL, PLTR: EPS without NRI Comparison
For the Software - Infrastructure subindustry, Gmo Product Platform's PE Ratio without NRI, along with its competitors' market caps and PE Ratio without NRI data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Gmo Product Platform PE Ratio without NRI vs Software Industry
For the Software industry and Technology sector, Gmo Product Platform's PE Ratio without NRI distribution charts can be found below:
* The bar in red indicates where Gmo Product Platform's PE Ratio without NRI falls into.
Earnings Per Share (EPS) is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.
Earnings Per Share without Non-Recurring Items is the amount of earnings without non-recurring items per outstanding share of the company's stock.
EPS without NRI for the trailing twelve months (TTM) ended in Dec. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was 円89.90
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Gmo Product Platform (TSE:3695) has a EPS without NRI of 円89.90 as of Dec. 2025. EPS without NRI represents per-share earnings excluding one-time charges. View historical data on Gmo Product Platform and its competitors. According to the industry distribution chart, Gmo Product Platform ranks #1879 out of 2077 companies in the Software industry, placing it in the top 90.5%.
Is Gmo Product Platform's EPS without NRI too high?
Gmo Product Platform's current EPS without NRI is 円89.90. Based on the distribution chart, Gmo Product Platform ranks #1879 out of 2077 companies in the Software industry, which is in the bottom quartile relative to peers. Overall, Gmo Product Platform has a GF Score™ of 71/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Gmo Product Platform's EPS without NRI compare to MSFT and ORCL?
According to the Software industry distribution chart, Gmo Product Platform ranks #1879 out of 2077 companies for EPS without NRI. This places Gmo Product Platform in the lower half of its industry. The industry median EPS without NRI is 12.50. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EPS without NRI for a Software company?
The median EPS without NRI among Software companies is 12.50, based on 2,077 companies in the industry. Companies in the top quartile (top 25%) have a EPS without NRI significantly above this median, while those in the bottom quartile fall well below. However, EPS without NRI should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EPS without NRI mean?
A high EPS without NRI can signal that a stock is expensive relative to its fundamentals. EPS without NRI represents per-share earnings excluding one-time charges. View historical data on Gmo Product Platform and its competitors. For the Software industry, the median EPS without NRI is 12.50 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Gmo Product Platform's current EPS without NRI is 円89.90. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Gmo Product Platform stock overvalued right now?
Based on GuruFocus' analysis, Gmo Product Platform (TSE:3695) is currently considered Fairly Valued. The stock's GF Value™ is 円1,480.31, compared to a current price of 円1,445.00 — trading 2.4% below its estimated fair value. The current EPS without NRI is 円89.90. Gmo Product Platform's overall GF Score™ is 71/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EPS without NRI calculated?
EPS without NRI is calculated from a company's financial statements. For Gmo Product Platform (TSE:3695), the current EPS without NRI is 円89.90 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Gmo Product Platform (TSE:3695) Overvalued in 2026?
Based on GuruFocus' analysis, Gmo Product Platform stock appears to be undervalued.
The current stock price of 円1,445.00 is trading 2.4% below its estimated GF Value™ of 円1,480.31.
GuruFocus considers Gmo Product Platform to be Fairly Valued.
Key valuation signals for TSE:3695:
EPS without NRI: 円89.90
GF Value™: 円1,480.31 vs. price of 円1,445.00 (2.4% below fair value)
No single metric tells the full story. See the TSE:3695 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Gmo Product Platform Inc offers online payment and business-to-business payment platform services that help startups, tech companies, and SMEs improve payment processing and operational efficiency. The solutions of the company support various business models with digital payment infrastructure and finance-related services.
71GF Score
Get the complete analysis for TSE:3695
EPS without NRI is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TSE:3695 has been successfully added to your 
